XL102

· Exelixis, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XL102, covering 2024-05-14 to 2024-05-14. Get the full timeline:

Most recent: Clinical Trial Update: Study of XL102 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (QUARTZ-101) [Phase 1]